Our group has shown that SiHa and CaSki HPV-positive cervical cancer-derived cell lines present higher levels of MMP-2, MT1-MMP, and TIMP-2 than the C33A HPV-negative cell line 53. This evidence concerns the gene MMP2 and cervical carcinoma.